Analysis of Regulatory Networks and Spatial Models Uncovers Mechanisms of Immune Evasion and Resistance in Estrogen Receptor-Positive Breast Cancer - Scorecard - MDSpire
Advertisement
Analysis of Regulatory Networks and Spatial Models Uncovers Mechanisms of Immune Evasion and Resistance in Estrogen Receptor-Positive Breast Cancer
Clinical Scorecard: Analysis of Regulatory Networks and Spatial Models Uncovers Mechanisms of Immune Evasion and Resistance in Estrogen Receptor-Positive Breast Cancer
At a Glance
Category
Detail
Condition
Key Mechanisms
Genetic alterations and acquired adaptive responses, including EMT and PD-L1 up-regulation, as observed in the study.
Target Population
Care Setting
Key Highlights
EMT is linked to tamoxifen resistance and immune evasion, as demonstrated in the study's findings.
Combination therapies may enhance treatment efficacy by addressing both endocrine resistance and immune evasion mechanisms.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Monitor PD-L1 expression and EMT markers (e.g., ZEB1, SLUG) to assess treatment response and adjust therapy accordingly.
Risks
Patient & Prescribing Data
All-trans retinoic acid (ATRA) may reverse EMT and improve survival in mesenchymal-like groups, with potential implications for other phenotypes.
Clinical Best Practices
Utilize specific transcriptomic signatures (e.g., those associated with ATRA response) for patient stratification.
Incorporate GRN-derived phenotypes into treatment planning, such as identifying patients likely to benefit from MET-inducing therapies.
